|
Advancing Today’s Knowledge on Gaucher Disease
- Andersson HC, Charrow J, Kaplan P, Kolodny EH, Mistry PK, Pastores GM. Consensus statement by the ICGG U.S. Regional Coordinators on individualization of enzyme replacement therapy (ERT) for type 1 Gaucher Disease. Available at: http://www.GaucherRegistry.com. Accessed June 11, 2007.
- de Fost M, Vom Dahl S, Weverling GJ, et al. Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis. Jan-Feb 2006;36(1):53-58.
- Lee RE. The pathology of Gaucher disease. Prog Clin Biol Res. 1982;95:177-217.
- Maaswinkel-Mooij P, Hollak C, van Eysden-Plaisier M, Prins M, Aerts H, Poll R. The natural course of Gaucher disease in The Netherlands: implications for monitoring of disease manifestations. J Inherit Metab Dis. Feb 2000;23(1):77-82.
- Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: The need for greater awareness among Hematologists-Oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. May 9 2007. DOI 10.1002/ajh.20908.
- Rosenbloom BE, Weinreb NJ, Zimran A, Kacena KA, Charrow J, Ward E. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood. Jun 15 2005;105(12):4569-4572.
- Weinreb NJ, Aggio MC, Andersson HC, et al. Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol. Oct 2004;41(4 Suppl 5):15-22.
- Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. Aug 1 2002;113(2):112-119.
|
|